Meropenem and Mean cell volume decreased - a phase IV clinical study of FDA data

Summary:

Mean cell volume decreased is reported only by a few people who take Meropenem.

The phase IV clinical study analyzes which people take Meropenem and have Mean cell volume decreased. It is created by eHealthMe based on reports of 22,665 people who have side effects while taking Meropenem from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 22, 2022

22,665 people reported to have side effects when taking Meropenem.
Among them, 5 people (0.02%) have Mean cell volume decreased.


What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 22,708 Meropenem users for its effectiveness, alternative drugs and more.

What is Mean cell volume decreased?

Mean cell volume decreased (less of the average red blood cell volume) is found to be associated with 544 drugs and 350 conditions by eHealthMe.

Number of Meropenem and Mean cell volume decreased reports submitted per year:

Could Meropenem cause Mean cell volume decreased?

Time on Meropenem when people have Mean cell volume decreased *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Mean cell volume decreased when taking Meropenem *:

  • female: 80 %
  • male: 20 %

Age of people who have Mean cell volume decreased when taking Meropenem *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 66.67 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 33.33 %

Common drugs people take besides Meropenem *:

  1. Phytomenadione: 2 people, 40.00%
  2. Pantoprazole: 2 people, 40.00%
  3. Magnesium: 2 people, 40.00%
  4. Lemtrada: 2 people, 40.00%
  5. Disodium Phosphate: 2 people, 40.00%

Common side effects people have besides Mean cell volume decreased *:

  1. Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 5 people, 100.00%
  2. Haemoglobin Decreased: 5 people, 100.00%
  3. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 5 people, 100.00%
  4. Thrombocytopenia (decrease of platelets in blood): 5 people, 100.00%
  5. White Blood Cell Count Increased: 4 people, 80.00%
  6. Ascites (accumulation of fluid in the abdominal cavity): 4 people, 80.00%
  7. Blood Bilirubin Increased: 4 people, 80.00%
  8. C-Reactive Protein Increased: 4 people, 80.00%
  9. Mean Cell Haemoglobin Decreased (less than normal haemoglobin per red blood cell in a sample of blood): 4 people, 80.00%
  10. Lymphocyte Percentage Decreased: 4 people, 80.00%

Common conditions people have *:

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 80.00%

* Approximation only. Some reports may have incomplete information.

Do you take Meropenem and have Mean cell volume decreased?

Check whether Mean cell volume decreased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of Meropenem:

Mean cell volume decreased treatments and more:

COVID vaccines that are related to Mean cell volume decreased:

How severe was Mean cell volume decreased and when was it recovered:

Expand to all the drugs that have ingredients of meropenem:

Common drugs associated with Mean cell volume decreased:

All the drugs that are associated with Mean cell volume decreased:

Common conditions associated with Mean cell volume decreased:

All the conditions that are associated with Mean cell volume decreased:

How the study uses the data?

The study uses data from the FDA. It is based on meropenem (the active ingredients of Meropenem) and Meropenem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: